bioRxiv Science⌕ Search

Biology subjects

Han, D. J.

Publications and source records attributed to Han, D. J..

2 recordsLinked to original sources

Telomerase reverse transcriptase is required for resistance to mycobacterial infection

Age is an important risk factor for infections such as tuberculosis (TB). Telomerase is expressed in immune cells yet leukocyte telomere length declines during ageing suggesting an age-dependent loss of telomerase activity in the immune system. Leukocyte telomere length has been correlated with worse outcomes in TB patients, however the mechanisms linking telomere biology to TB susceptibility and response to therapy are unexplored. Here we use the zebrafish-Mycobacterium marinum model to investigate the role of telomerase in TB resistance. We find depletion and inhibition of Tert, the catalytic subunit of telomerase, increases bacterial burden in zebrafish embryos. The Tert depletion infection susceptibility phenotype could not be rescued by p53 or STING depletion suggesting a non-canonical role for Tert in controlling mycobacterial infection. Consistent with a previously described role for Tert in developmental hematopoiesis, we find Tert is necessary for demand-driven emergency myelopoiesis to support containment of extended mycobacterial infection. Our findings establish a previously undescribed role for host telomerase in supporting infection demand-driven hematopoiesis to control infection.

immunology↗

The repurposed STAT3 inhibitor pyrimethamine controls mycobacterial infection-induced vascular permeability and mycobacterial burden

Infection-induced vascular pathologies are a side effect of the immune response to contact with a range of pathogens. Mycobacteria, including Mycobacterium tuberculosis, are particularly adept at co-opting vascular leakiness as a survival mechanism to shape the host immune response and impede the delivery of antibiotics to sites of infection. Here using the zebrafish-Mycobacterium marinum infection model, we confirm a critical role for Signal transducer and activator of transcription 3 (STAT3) in mediating infection-induced vascular permeability, and demonstrate the ability of FDA-approved drugs atovaquone and pyrimethamine to restore vascular barrier function without compromising immune control of mycobacterial infection. Additionally, we find an antibiotic effect of pyrimethamine against Mycobacterium marinum via inhibition of bacterial dihydrofolate reductase. Together our findings suggest pyrimethamine could be used as adjunctive therapy against mycobacterial infection.

microbiology↗